Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Indian Journal of Trauma and Emergency Pediatrics

Volume  4, Issue 4, October - December 2012, Pages 147-152
 

Review Article

Management of Pediatric/Neonatal Emergencies Current Evidence from Cochrane/Other systematic Reviews (Clinical Question: Second Line Agent in Status Epilepticus: Phenytoin or Valproate)

Deepak Sachan

*Associate Professor, Department of Pediatrics, Postgraduate Institute of Medical Education and Research (PGIMER), Dr R.M.L Hospital, New Delhi.

Choose an option to locate / access this Article:
90 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI:

Abstract

In this article, we have tried to review the evidence regarding the use of second line agents in status epilepticus, comparing phenytoin and valproate in particular. While phenytoin continues to be used as the preferred second line agent, valproate is equally effective and safe. However, there is need for generating more evidence particularly with respect to safety profile of these two drugs in comparison to each other so that, a consensus may be arrived at in future as to, which is the best second line drug among these two agents in terms of both safety and efficacy.

Keywords: Phenytoin, Valproate; Status epilepticus; Second line agents; Diazepam; Midazolam.


Corresponding Author : Deepak Sachan